Auriculotherapy in the adult chemotherapy clinic: a complementary proposalcombined with nursing care to relieve nausea and vomiting

Not Applicable

• Conditions: Drug therapy; Nausea; Vomiting; C23.888.821.712; C23.888.821.937; E02.319

• Registration Number: RBR-5d4xkm
• Lead Sponsor: niversidade Federal Fluminense

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-11-17
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Adult men aged 18 to 59 years diagnosed with cancer, undergoing chemotherapy from the second cycle with protocols with the following drugs with a high degree of emetogenicity: Combination AC (Doxorubicin + Cyclophosphamide), Carboplatin (AUC greater than or equal to 4mg / m²), Cisplatin, Cyclophosphamide (greater than or equal to 1500mg / m²), Dacarbazine, Doxorubicin (greater than or equal to 60mg / m²), Epirubicin (greater than 90mg / m²) and Ifosfamide (greater than or equal to 2g / m²). In addition, patients with previous experience of nausea and vomiting regarding previous chemotherapy and presentation of the KPS (Karnofsky Performance Status) scale above 70%.

Exclusion Criteria

Adult men with cognitive deficit described in medical records; with previous gastrointestinal diseases or previous anti-ulcer treatment; cancer located in the stomach, due to the interference of the disease in the control of nausea and vomiting; neoplasms located in the Central Nervous System (CNS), as they can interfere in the center of vomiting; previous history of allergy to antiallergic micropose patch or any other patch currently available; patients who started outpatient chemotherapy but were hospitalized, for some reason, and continued inpatient chemotherapy, as they receive intravenous antiemetic medication every 8 hours and prolonged venous hydration, which could be a bias for the research. And previous history of use of antiemetics that are not standardized by the hospital.

Study & Design

• Study Type: Intervention
• Study Design: Not specified